Should we use Palivizumab immunoprophylaxis for infants against respiratory syncytial virus? – a cost-utility analysis by Gary M. Ginsberg, Eli Somekh, Yechiel Schlesinger

Subjects: “…Cost-utility analysis…”
Get full text

Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis by Saharat Aungsumart, Saowalak Turongkaravee, Sitaporn Youngkong, Metha Apiwattanakul, Ammarin Thakkinstian, Usa Chaikledkaew

Subjects: Get full text

Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure by Praveen Thokala, Baalbaki Hassan, Pandor Abdullah, John W. Stevens, Brennan Alan

Subjects: “…cost-utility analysis…”
Get full text

Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure by Praveen Thokala, Baalbaki Hassan, Pandor Abdullah, John W. Stevens, Brennan Alan

Subjects: “…cost-utility analysis…”
Get full text

Cost-Utility Analysis of Open Hernia Operations in Bulgaria by Kirilova-Doneva M., Kamusheva M., Gerasimov N., Petrova G.

Subjects: “…cost-utility analysis…”
Get full text

Economic Evaluation of Cataract: A Systematic Mapping Review by José Ginel, Noemi Burguera, Carlos Rocha-de-Lossada, David Piñero, Alejandro Sáez-Martín, Joaquín Fernández

Subjects: Get full text

Budget impact and cost-utility analysis of prophylactic emicizumab versus on-demand bypassing agents for adolescent severe haemophilia A patients with inhibitors in India by Yuvaraj Krishnamoorthy, Dhanajayan Govindan, Narasimhapriyan Kannan, Marie Gilbert Majella, Vishnu Shankar Hariharan, Vivek Valliappan

Subjects: “…Cost utility analysis…”
Get full text

Economic Evaluation of Dulaglutide vs Traditional Therapies: Implications of the Outcomes of the Rewind Study by Torre E, Bruno GM, Di Matteo S, Martinotti C, Valentino MC, Bottaro LC, Colombo GL

Subjects: Get full text

[Cost-Utility Analysis of Dupilumab for the Treatment of Severe Atopic Dermatitis in Children and Adolescents in Italy] by Elena Galli, Maria Paola Pedone, Miryana Dobreva, Rossella Bitonti, Roberta Di Turi

Subjects: Get full text

Cost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain by Santiago Moreno Guillen, Juan Emilio Losa García, Juan Berenguer Berenguer, José Manuel Martínez Sesmero, Santiago Cenoz Gomis, Ruth Graefenhain, David Lopez Sanchez-Cambronero, Francisco Javier Parrondo Garcia

Subjects: Get full text

A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma by Bozzani Fiammetta Maria, Alavi Yasmene, Jofre-Bonet Mireia, Kuper Hannah

Subjects: Get full text

REASONS FOR DIFFICULTY OF THE PHARMACOECONOMIC ANALYSIS FOR ORPHAN DRUGS. WAYS FOR SOLUTIONS by Andrey Vladislavovich Pavlysh, Aleksei Sergeevich Kolbin, Roman Andreevich Gapeshin, Stanislav Mikhailovich Malyshev

Subjects: Get full text

Cost-utility analysis of bariatric surgery compared with conventional medical management in Germany: a decision analytic modeling by Oleg Borisenko, Oliver Mann, Anna Duprée

Subjects: Get full text

Cost utility analysis of long-term telemonitoring of patients with DMT2: Results of the Greek pilot of the renewing health multicenter pragmatic randomized trial by George E. Dafoulas, Afentoula Mavrodi, Alexandra Bargiota, Haralambos Giannakakos, Panagiotis Stafylas, Paraskevi Gkiata, Petros Pechlivangolou, Kyriaki Theodorou, Georgios Koukoulis, Vasilios Aletras

Subjects: Get full text

Cost-effectiveness of Descemet stripping automated endothelial keratoplasty versus penetrating keratoplasty in patients with endothelial dysfunction in India by Pooja Shah, Ritika Mukhija, Noopur Gupta, M Vanathi, Radhika Tandon

Subjects: Get full text

Cost-utility analysis in chronic kidney disease patients undergoing kidney transplant; what pays? A systematic review by Sameera Senanayake, Nicholas Graves, Helen Healy, Keshwar Baboolal, Sanjeewa Kularatna

Subjects: Get full text

Neonatal Screening: Cost-utility Analysis for Galactosemia by Nahid HATAM, Mehrdad ASKARIAN, Samad SHIRVANI, Elham SIAVASHI

Subjects: Get full text

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand by Peerapatanapokin Wiwat, Namwat Chawetsan, Premsri Nakorn, Akaleephan Chutima, Werayingyong Pitsaphun, Teerawattananon Yot, Leelahavarong Pattara, Tangcharoensathien Viroj

Subjects: Get full text

The economic impact of two diagnostic strategies in the management of restorations in primary teeth: a health economic analysis plan for a trial-based economic evaluation by Raíza Dias Freitas, Bruna Lorena Pereira Moro, Laura Regina Antunes Pontes, Haline Cunha Medeiros Maia, Ana Laura Passaro, Rodolfo Carvalho Oliveira, Jonathan Rafael Garbim, Maria Eduarda Franco Vigano, Tamara Kerber Tedesco, Christopher Deery, Daniela Prócida Raggio, Maximiliano Sergio Cenci, Fausto Medeiros Mendes, Mariana Minatel Braga, CARDEC collaborative group - CARDEC-03 trial

Subjects: Get full text

Cost-utility analysis of using paliperidone palmitate in schizophrenia in China by Rui Luo, He Lu, Hengfen Li

Subjects: Get full text